(Q34261329)

English

Policy statement on antimicrobial stewardship by the Society for Healthcare Epidemiology of America (SHEA), the Infectious Diseases Society of America (IDSA), and the Pediatric Infectious Diseases Society (PIDS).

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Policy statement on antimicrobial stewardship by the Society for Healthcare Epidemiology of America (SHEA), the Infectious Diseases Society of America (IDSA), and the Pediatric Infectious Diseases Society (PIDS). (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

1 reference

based on heuristic

inferred from title

Infectious Diseases Society of America

2

object named as

Infectious Diseases Society of America

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Society for Healthcare Epidemiology of America

1

object named as

Society for Healthcare Epidemiology of America

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Pediatric Infectious Diseases Society

3

object named as

Pediatric Infectious Diseases Society

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 April 2012

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Infection Control and Hospital Epidemiology

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

33

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

322-327

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Excess costs and utilization associated with methicillin resistance for patients with Staphylococcus aureus infection

1 reference

https://api.crossref.org/works/10.1086%2F665010

21 January 2018

Vancomycin-resistant enterococci: why are they here, and where do they come from?

1 reference

https://api.crossref.org/works/10.1086%2F665010

21 January 2018

Antimicrobial resistance in typhoidal and nontyphoidal salmonellae

1 reference

https://api.crossref.org/works/10.1086%2F665010

21 January 2018

Emergence and spread of drug resistant Neisseria gonorrhoeae

1 reference

https://api.crossref.org/works/10.1086%2F665010

21 January 2018

Combating antimicrobial resistance: policy recommendations to save lives

1 reference

https://api.crossref.org/works/10.1086%2F665010

21 January 2018

Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship

1 reference

https://api.crossref.org/works/10.1086%2F665010

21 January 2018

Imipenem resistance among pseudomonas aeruginosa isolates: risk factors for infection and impact of resistance on clinical and economic outcomes.

1 reference

https://api.crossref.org/works/10.1086%2F665010

21 January 2018

Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America

1 reference

https://api.crossref.org/works/10.1086%2F665010

21 January 2018

The 10 x '20 Initiative: pursuing a global commitment to develop 10 new antibacterial drugs by 2020.

1 reference

https://api.crossref.org/works/10.1086%2F665010

21 January 2018

Attributable hospital cost and length of stay associated with health care-associated infections caused by antibiotic-resistant gram-negative bacteria

1 reference

https://api.crossref.org/works/10.1086%2F665010

21 January 2018

Treatment outcomes among patients with extensively drug-resistant tuberculosis: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1086%2F665010

21 January 2018

Community-associated meticillin-resistant Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1086%2F665010

21 January 2018

Comparison of community- and health care-associated methicillin-resistant Staphylococcus aureus infection

1 reference

https://api.crossref.org/works/10.1086%2F665010

21 January 2018

Use of plasma procalcitonin levels as an adjunct to clinical microbiology

1 reference

https://api.crossref.org/works/10.1086%2F665010

21 January 2018

Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk

1 reference

https://api.crossref.org/works/10.1086%2F665010

21 January 2018

An unmet medical need: rapid molecular diagnostics tests for respiratory tract infections

1 reference

https://api.crossref.org/works/10.1086%2F665010

21 January 2018

Methicillin-resistant Staphylococcus aureus at Boston City Hospital. Bacteriologic and epidemiologic observations

1 reference

https://api.crossref.org/works/10.1086%2F665010

21 January 2018

QUANTITATIVE ACTION OF PENICILLIN INHIBITOR FROM PENICILLIN-RESISTANT STRAINS OF STAPHYLOCOCCI.

1 reference

https://api.crossref.org/works/10.1086%2F665010

21 January 2018

The clinical consequences of antimicrobial resistance

1 reference

https://api.crossref.org/works/10.1086%2F665010

21 January 2018

Pathogens resistant to antibacterial agents

1 reference

https://api.crossref.org/works/10.1086%2F665010

21 January 2018

Pandrug-resistant Klebsiella pneumoniae, Pseudomonas aeruginosa and Acinetobacter baumannii infections: characteristics and outcome in a series of 28 patients

1 reference

https://api.crossref.org/works/10.1086%2F665010

21 January 2018

Multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii: resistance mechanisms and implications for therapy

1 reference

https://api.crossref.org/works/10.1086%2F665010

21 January 2018

Multiresistant Acinetobacter baumannii infections: epidemiology and management

1 reference

https://api.crossref.org/works/10.1086%2F665010

21 January 2018

Extended-spectrum [beta]-lactamase producing Escherichia coli: changing epidemiology and clinical impact

1 reference

https://api.crossref.org/works/10.1086%2F665010

21 January 2018

Multiresistant Gram-negative infections: a global perspective

1 reference

https://api.crossref.org/works/10.1086%2F665010

21 January 2018

The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria

1 reference

https://api.crossref.org/works/10.1086%2F665010

21 January 2018

Vancomycin-resistant Staphylococcus aureus: a new model of antibiotic resistance

1 reference

https://api.crossref.org/works/10.1086%2F665010

21 January 2018

Vancomycin-resistant enterococci: 15 years and counting

1 reference

https://api.crossref.org/works/10.1086%2F665010

21 January 2018

Outcomes of carbapenem-resistant Klebsiella pneumoniae infection and the impact of antimicrobial and adjunctive therapies

1 reference

https://api.crossref.org/works/10.1086%2F665010

21 January 2018

Identifiers

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34261329&oldid=1752737406"